Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-000006

CEO and CFO bought 4,000 shares at $15.19 ($60,760)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2022-12-29 Purchase +4,000 $15.19 $60,760 2,729,886 D: show line 1 in the form
Open-market purchases · 4,000 sh · avg $15.19 · $60,760
Loading xslF345X03/ownership.xml…